«
Newer epilepsy drugs taken while pregnant not linked to lower IQs in children.»
Two
newer epilepsy drugs may not harm the thinking skills or IQs of school - aged children whose mothers took them while pregnant — but an older drug is linked to cognitive problems in children, especially if their mothers took high doses — according to new research from The University of Manchester.
New epilepsy drugs were invented during the 30's, 40's and 50's and ketogenic diets fell to the wayside.
Not exact matches
He added that many
drug companies have stopped their research into finding
new medicines for
epilepsy.
But
new research holds out hope that
drugs developed to treat other neurological problems — notably
epilepsy — could rein in the compulsive and blind drive to eat at the core of the disorder.
As many as three million people in the U.S. live with
epilepsy, and more than 30 percent of them receive inadequate relief from medication, a number that persists despite the introduction of more than a dozen
new antiepileptic
drugs since 1990.
A 2013 joint report from
epilepsy research organizations explained that «because the marketplace is already awash with [antiseizure
drugs], many pharmaceutical companies now refrain from the expensive enterprise of developing
new compounds.»
In addition, the creation of a zebrafish model for CHD2 encephalopathy may facilitate the discovery of
new drugs that can treat patients with this form of
epilepsy.
«
New insights into
epilepsy drug Retigabine: Retigabine holds KV7 channels open, stabilizes the resting potential.»
The researchers hope that the
drug - like substances can be developed into
new drugs against
epilepsy.
The discovery opens the possibility of designing
new types of
drugs against conditions such as
epilepsy.
«Scientists find potential
epilepsy drug:
New molecule prevents recurrent temporal lobe
epilepsy in mice.»
Specifically, they tested
new drugs in zebrafish, a small, tropical fish genetically similar to humans, whose brains can develop seizures in a manner similar to patients with
epilepsy.
Investigating the effectiveness of the ketogenic diet led researchers at the Cumming School of Medicine to develop a
new drug screening method to discover
drugs to treat
epilepsy.
A major advantage of using valproic acid is that it's already approved as an
epilepsy drug by the Food and Drug Administration, so if it were ever to be used in humans, it wouldn't have to go through the same long, expensive approval process that a new compound would requ
drug by the Food and
Drug Administration, so if it were ever to be used in humans, it wouldn't have to go through the same long, expensive approval process that a new compound would requ
Drug Administration, so if it were ever to be used in humans, it wouldn't have to go through the same long, expensive approval process that a
new compound would require.
The agency proposed to ease the guidelines for the approval of
new drugs for Alzheimer's,
epilepsy, migraine, and ALS.
October 27, 2011
Drug treatment shows promise for brain blood vessel abnormality A drug treatment has been proven to prevent lesions from cerebral cavernous malformation — a brain blood vessel abnormality that can cause bleeding, epilepsy and stroke — for the first time in a new st
Drug treatment shows promise for brain blood vessel abnormality A
drug treatment has been proven to prevent lesions from cerebral cavernous malformation — a brain blood vessel abnormality that can cause bleeding, epilepsy and stroke — for the first time in a new st
drug treatment has been proven to prevent lesions from cerebral cavernous malformation — a brain blood vessel abnormality that can cause bleeding,
epilepsy and stroke — for the first time in a
new study.
Even though Johns Hopkins used a ketogenic diet for curing
epilepsy over 80 years ago, when medical
drugs did not help
epilepsy effectively, mainstream medicine continues to rely on
new and expensive toxic
drugs for epileptic children.
Potassium bromide (KBr or bromide) is gaining
new recognition for use in refractory (difficult to control) canine
epilepsy as well as a first - line
drug therapy.